Cargando…
Elucidating the Therapeutic Potential of Bis(Maltolato)OxoVanadium(IV): The Protective Role of Copper in Cellular Metabolism
Vanadium (V) is a trace mineral whose biological activity, role as a micronutrient, and pharmacotherapeutic applications remain unknown. Over the last years, interest in V has increased due to its potential use as an antidiabetic agent mediated by its ability to improve glycemic metabolism. However,...
Autores principales: | Rivas-García, Lorenzo, López-Varela, Alfonso, Quiles, José L., Montes-Bayón, María, Aranda, Pilar, Llopis, Juan, Sánchez-González, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253854/ https://www.ncbi.nlm.nih.gov/pubmed/37298322 http://dx.doi.org/10.3390/ijms24119367 |
Ejemplares similares
-
Effect of Bis(maltolato)oxovanadium(IV) on Zinc, Copper, and Manganese Homeostasis and DMT1 mRNA Expression in Streptozotocin-Induced Hyperglycemic Rats
por: Sánchez-González, Cristina, et al.
Publicado: (2022) -
Changes in Iron Metabolism and Oxidative Status in STZ-Induced Diabetic Rats Treated with Bis(maltolato) Oxovanadium (IV) as an Antidiabetic Agent
por: Sánchez-González, Cristina, et al.
Publicado: (2014) -
Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B
por: Scior, Thomas, et al.
Publicado: (2009) -
Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2
por: Parma, Laura, et al.
Publicado: (2020) -
Bis maltolato oxovanadium (BMOV) and ischemia/reperfusion-induced acute kidney injury in rats
por: Almac, Emre, et al.
Publicado: (2014)